chr21-33559742-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BS1BS2
The ENST00000356577.10(SON):āc.6624T>Cā(p.Asp2208=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000345 in 1,613,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.00020 ( 0 hom., cov: 32)
Exomes š: 0.00036 ( 0 hom. )
Consequence
SON
ENST00000356577.10 synonymous
ENST00000356577.10 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.571
Genes affected
SON (HGNC:11183): (SON DNA and RNA binding protein) This gene encodes a protein that contains multiple simple repeats. The encoded protein binds RNA and promotes pre-mRNA splicing, particularly of transcripts with poor splice sites. The protein also recognizes a specific DNA sequence found in the human hepatitis B virus (HBV) and represses HBV core promoter activity. There is a pseudogene for this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 21-33559742-T-C is Benign according to our data. Variant chr21-33559742-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 2169988.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.571 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000204 (31/152174) while in subpopulation NFE AF= 0.000397 (27/68022). AF 95% confidence interval is 0.00028. There are 0 homozygotes in gnomad4. There are 16 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 31 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SON | NM_138927.4 | c.6624T>C | p.Asp2208= | synonymous_variant | 6/12 | ENST00000356577.10 | NP_620305.3 | |
SON | NM_032195.3 | c.6624T>C | p.Asp2208= | synonymous_variant | 6/7 | NP_115571.3 | ||
SON | NM_001291412.3 | c.708T>C | p.Asp236= | synonymous_variant | 5/11 | NP_001278341.1 | ||
SON | NR_103797.2 | n.6679T>C | non_coding_transcript_exon_variant | 6/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SON | ENST00000356577.10 | c.6624T>C | p.Asp2208= | synonymous_variant | 6/12 | 1 | NM_138927.4 | ENSP00000348984 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152174Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
31
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000108 AC: 27AN: 250744Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135746
GnomAD3 exomes
AF:
AC:
27
AN:
250744
Hom.:
AF XY:
AC XY:
18
AN XY:
135746
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000360 AC: 526AN: 1461736Hom.: 0 Cov.: 32 AF XY: 0.000344 AC XY: 250AN XY: 727162
GnomAD4 exome
AF:
AC:
526
AN:
1461736
Hom.:
Cov.:
32
AF XY:
AC XY:
250
AN XY:
727162
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000204 AC: 31AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74338
GnomAD4 genome
AF:
AC:
31
AN:
152174
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
74338
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at